The authors have disclosed that they have no financial interests, arrangements, or affiliations with the manufacturers of any products discussed in this article or their competitors.
GreerBEKohWJAbu-RustemNR. NCCN Clinical Practice Guidelines in Oncology for Uterine Neoplasms. Version 22012. Available at: http://www.nccn.org/professionals/physician_gls/pdf/uterine.pdf. Accessed March 1 2012.
SiegelRWardEBrawleyOJemalA. Cancer statistics, 2011: the impact of eliminating socioeconomic and racial disparities on premature cancer deaths. CA Cancer J Clin2011;61:212–236.
CreasmanWOdicinoFMaisonneuveP. Carcinoma of the corpus uteri. FIGO 26th annual report on the results of treatment in gynecological cancer. Int J Gynaecol Obstet2006;95(Suppl 1):S105–143.
BenedtJLBenderHJonesH. FIGO staging classifications and clinical practice guidelines in the management of gynecologic cancers. FIGO committee on gynecologic oncology. Int J Gynaecol Obset2000;70:209–262.
RoperBAstnerSTHeydemann-ObradovicA. Ten-year data on 138 patients with endometrial carcinoma and postoperative vaginal brachytherapy alone: no need for external radiotherapy in low and intermediate risk patients. Gynecol Oncol2007;107:541–548.
StrughnJMJrHuhWKKellyFJ. Conservative management of stage I endometrial carcinoma after surgical staging. Gynecol Oncol2002;84:194–200.
MorrowCPBundyBNKurmanRJ. Relationship between surgical-pathological risk factors and outcome in clinical stage I and II carcinoma of the endometrium: a Gynecologic Oncology Group study. Gynecol Oncol1991;40:50–65.
KeysHMRobertsJABrunettoVL. A phase III trial of surgery with or without adjunctive external pelvic radiation therapy in intermediate risk endometrial adenocarcinoma: a Gynecologic Oncology Group study. Gynecol Oncol2004;92:744–751.
CreutzbergCLVan PuttenWLKoperPC. For the PORTEC Study Group: surgery and postoperative radiotherapy versus surgery alone for patients with stage-I endometrial carcinoma: multicentre randomised trial. Lancet2000;355:1404–1411.
AckermanIMaloneSThomasG. Endometrial carcinoma-relative effectiveness of adjuvant irradiation vs therapy reserved for salvage. Gynecol Oncol1996;60:177–183.
CreutzbergCLvan PuttenWLKoperPC. For the PORTEC Study Group: survival after relapse in patients with endometrial cancer. Results from a randomised trial. Gynecol Oncol2003;89:201–209.
LinLLGrigsbyPWPowellMAMutchDG. Definitive radiotherapy in the management of isolated vaginal recurrences of endometrial cancer. Int J Radiat Oncol Biol Phys2005;63:500–504.